Cargando…

Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning

Background: Markov decision process (MDP) models are powerful tools. They enable the derivation of optimal treatment policies but may incur long computational times and generate decision rules that are challenging to interpret by physicians. Methods: In an effort to improve usability and interpretab...

Descripción completa

Detalles Bibliográficos
Autores principales: Schell, Greggory J., Marrero, Wesley J., Lavieri, Mariel S., Sussman, Jeremy B., Hayward, Rodney A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124941/
https://www.ncbi.nlm.nih.gov/pubmed/30288409
http://dx.doi.org/10.1177/2381468316674214
_version_ 1783353107150798848
author Schell, Greggory J.
Marrero, Wesley J.
Lavieri, Mariel S.
Sussman, Jeremy B.
Hayward, Rodney A.
author_facet Schell, Greggory J.
Marrero, Wesley J.
Lavieri, Mariel S.
Sussman, Jeremy B.
Hayward, Rodney A.
author_sort Schell, Greggory J.
collection PubMed
description Background: Markov decision process (MDP) models are powerful tools. They enable the derivation of optimal treatment policies but may incur long computational times and generate decision rules that are challenging to interpret by physicians. Methods: In an effort to improve usability and interpretability, we examined whether Poisson regression can approximate optimal hypertension treatment policies derived by an MDP for maximizing a patient’s expected discounted quality-adjusted life years. Results: We found that our Poisson approximation to the optimal treatment policy matched the optimal policy in 99% of cases. This high accuracy translates to nearly identical health outcomes for patients. Furthermore, the Poisson approximation results in 104 additional quality-adjusted life years per 1000 patients compared to the Seventh Joint National Committee’s treatment guidelines for hypertension. The comparative health performance of the Poisson approximation was robust to the cardiovascular disease risk calculator used and calculator calibration error. Limitations: Our results are based on Markov chain modeling. Conclusions: Poisson model approximation for blood pressure treatment planning has high fidelity to optimal MDP treatment policies, which can improve usability and enhance transparency of more personalized treatment policies.
format Online
Article
Text
id pubmed-6124941
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61249412018-10-04 Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning Schell, Greggory J. Marrero, Wesley J. Lavieri, Mariel S. Sussman, Jeremy B. Hayward, Rodney A. MDM Policy Pract Original Article Background: Markov decision process (MDP) models are powerful tools. They enable the derivation of optimal treatment policies but may incur long computational times and generate decision rules that are challenging to interpret by physicians. Methods: In an effort to improve usability and interpretability, we examined whether Poisson regression can approximate optimal hypertension treatment policies derived by an MDP for maximizing a patient’s expected discounted quality-adjusted life years. Results: We found that our Poisson approximation to the optimal treatment policy matched the optimal policy in 99% of cases. This high accuracy translates to nearly identical health outcomes for patients. Furthermore, the Poisson approximation results in 104 additional quality-adjusted life years per 1000 patients compared to the Seventh Joint National Committee’s treatment guidelines for hypertension. The comparative health performance of the Poisson approximation was robust to the cardiovascular disease risk calculator used and calculator calibration error. Limitations: Our results are based on Markov chain modeling. Conclusions: Poisson model approximation for blood pressure treatment planning has high fidelity to optimal MDP treatment policies, which can improve usability and enhance transparency of more personalized treatment policies. SAGE Publications 2016-10-17 /pmc/articles/PMC6124941/ /pubmed/30288409 http://dx.doi.org/10.1177/2381468316674214 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Schell, Greggory J.
Marrero, Wesley J.
Lavieri, Mariel S.
Sussman, Jeremy B.
Hayward, Rodney A.
Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning
title Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning
title_full Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning
title_fullStr Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning
title_full_unstemmed Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning
title_short Data-Driven Markov Decision Process Approximations for Personalized Hypertension Treatment Planning
title_sort data-driven markov decision process approximations for personalized hypertension treatment planning
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124941/
https://www.ncbi.nlm.nih.gov/pubmed/30288409
http://dx.doi.org/10.1177/2381468316674214
work_keys_str_mv AT schellgreggoryj datadrivenmarkovdecisionprocessapproximationsforpersonalizedhypertensiontreatmentplanning
AT marrerowesleyj datadrivenmarkovdecisionprocessapproximationsforpersonalizedhypertensiontreatmentplanning
AT lavierimariels datadrivenmarkovdecisionprocessapproximationsforpersonalizedhypertensiontreatmentplanning
AT sussmanjeremyb datadrivenmarkovdecisionprocessapproximationsforpersonalizedhypertensiontreatmentplanning
AT haywardrodneya datadrivenmarkovdecisionprocessapproximationsforpersonalizedhypertensiontreatmentplanning